Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion type Assertion NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_head.
- NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion wasGeneratedBy ECO_0000203 NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_provenance.
- NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion wasDerivedFrom befree-2016 NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_provenance.
- NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion SIO_000772 7642169 NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_provenance.
- NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion evidence source_evidence_literature NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_provenance.
- NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_assertion description "[These studies have led to the conclusion that the cellular origin or pathogenesis of ILL/IDL and DSCCL is distinctly different from that of FSCCL: (1) FSCCL is a neoplastic counterpart of follicular center cells (FCC) of secondary follicles because of the presence of CD10 and bcl-2 gene rearrangement and the absence of CD5 and bcl-1 gene rearrangement; (2) DSCCL and ILL/IDL are a neoplastic counterpart of mantle zone (MZ) B lymphocytes because of the presence of CD5 and bcl-1 gene rearrangement and absence of CD10 and bcl-2 gene rearrangement; and (3) FSCCL scarcely develops into DSCCL, and the previously proposed concept that DSCCL represents a diffuse counterpart of FSCCL does not hold good.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316292.RA4pr9TUyimrDBeN1T6k0pmiD2Rx5kqC0MGSbcRkr874k130_provenance.